Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
Clinical trial NCT01396083 · COMPLETED
Trial details
- NCT number
- NCT01396083
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2014-01-01
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.